On February 11, Upstream News reported that Chongqing will launch free cervical cancer vaccination for women of appropriate age in 2022, and the news caused a heated discussion this past weekend. An investigation by upstream journalists found that women in Chongqing have always been very willing to vaccinate against cervical cancer.
More than 100 million people read related topics
Netizen: "Finally waiting for you"
As of 3 p.m. on February 14, the topic "Chongqing will vaccinate women of the right age free of charge against cervical cancer" initiated by the official Weibo of Chongqing Morning Post has been read more than 110 million times, and this topic has aroused heated discussion on the Internet in the past two days. Many netizens directly called "envy" on Weibo, and netizens "Flowing Clouds Flying 8888" left a message under the topic, "Chongqing is really good!" There are also netizens calling for their own cities online, "Learn! Although the specific implementation plan has not yet been released, but there are already many netizens full of expectations, netizens "black circles small M" said, "my age is estimated to be unable to catch up, but my daughter can still enjoy the policy!" ”
"This weekend, the circle of friends has brushed the screen, and they are all saying that they are finally waiting for you!" Ms. Wang, who lives in Jinke Ten Years City in Jiangbei District, has just received the second dose of HPV vaccine, and she transferred the good news to her girlfriend group and told her two girlfriends with daughters, "Baby is blessed!" ”
Four-valent and nine-valent vaccines in many places in Chongqing are out of stock
Domestic bivalent vaccines can be booked online
Since 2017, cervical cancer vaccines have been fully covered in Chongqing, and the public can choose to receive bivalent, quadrivalent and 9-valent vaccines at various vaccination sites in Chongqing. Among them, the domestic bivalent cervical cancer vaccine is 369 yuan a shot, the imported bivalent cervical cancer vaccine is 605 yuan a shot; the quadrivalent cervical cancer vaccine is an imported vaccine, 823 yuan a shot, the nine-valent cervical cancer vaccine is also an imported vaccine, 1323 yuan a shot, cervical cancer vaccine needs to be vaccinated three times, currently a self-funded vaccine.
On February 14, upstream reporters contacted the vaccination sites of multiple street health service centers in Yuzhong District, Jiangbei District, Liangjiang New District and Beibei District in the central urban area of Chongqing, and all the vaccination points said that they could not receive the quadrivalent HPV vaccine and the nine-valent HPV vaccine at present. However, most vaccination sites can still receive domestic bivalent cervical cancer vaccines, but some of them require the vaccinator to receive the second or third dose, "If the first injection cannot be vaccinated, you must finish the front line first." ”
When the reporter asked how to make an appointment to queue up for vaccination, multiple vaccination site staff suggested that the reporter make an appointment on WeChat through the vaccine appointment mini program, but when the reporter opened the mini program, the nine-valent cervical cancer vaccine appointment page of most of the vaccination points directly displayed "out of stock", and the four-valent cervical cancer vaccine part of the vaccination point appointment page required the person to subscribe to the seedling notice, and asked to "complete the appointment within 12 hours of receiving the subscription notice." ”
The "about Miao" road between mother and daughter
The daughter returned to Changsha half a month earlier for vaccination
Upstream journalists combed and found that in fact, except for Chongqing, the shortage of cervical cancer vaccines has occurred throughout the country, and some places even need to queue for half a year or more.
Seeing the news that Chongqing will give free cervical cancer vaccines to women of the right age, Zhao Ting (pseudonym), 40 years old this year, felt a lot, "It is a big welfare for women in Chongqing, but I still hope that the amount of vaccine is larger, it is really difficult to agree." In 2017, the second day of the four-valent vaccine in Chongqing, Ms. Zhao received the first dose of the four-valent cervical cancer vaccine at the Daxigou Community Health Service Center in Yuzhong District, "I saw the news and went directly to the miao, the next day I hit it, and then friends who made an appointment two days later than me began to queue up to wait for the seedlings." ”
Ms. Zhao recalled that in 2017, the enthusiasm of Chongqing people to receive cervical cancer vaccine was very high, and every time she went to get vaccinated, she could meet citizens who came to the door to make an appointment for vaccination, but many people did not make a successful appointment, "there is no seedling, there is a queue." "There are so many people in the queue that we don't know how long we're going to be in line." In 2018, when Ms. Zhao went to the community health service center to get the third dose of cervical cancer vaccine, she heard the staff say on the phone, "At least until 3 months later." ”
Ms. Zhao's daughter is 19 years old this year, is in Changsha sophomore year, Ms. Zhao has been with her daughter in Chongqing and Changsha to help her daughter make a cervical cancer vaccine appointment in Chongqing and Changsha since she went to college, "We want to about nine prices, but we can't say it, and now we don't even let the queue be queued." The mother and daughter lined up at multiple community health centers in Chongqing and Changsha to make an appointment for a quadrivalent cervical cancer vaccine.
On February 10, a vaccination site in Changsha suddenly called Ms. Zhao's daughter and asked her to get vaccinated as soon as possible, "If you can't go there, you should give up." At this time, there are still 10 days before the start of the school year for her daughter, and moreover, Ms. Zhao's daughter's university cannot return to school in advance due to epidemic prevention and control requirements, and the mother and daughter quickly discussed and decided to let the daughter immediately buy a ticket for the night to return to Changsha, "I booked a hotel near her school, if this time can't be called, I don't know how long it will be." ”
Cervical cancer ranks fifth in Chongqing for women with the highest incidence of cancer
According to the 2020 new tumor registration data of Chongqing Municipality, the incidence of cervical cancer in Chongqing is about 20.58 people per 100,000 people, ranking fifth in chongqing for women with high incidence of cancer.
Zhou Qi, discipline leader and chief physician of the Gynecology Cancer Center of the Affiliated Cancer Hospital of Chongqing University, introduced that in the malignant tumors of the female reproductive system in China, the incidence and mortality of cervical cancer rank first, "HPV vaccination and cervical screening are effective ways to prevent cervical cancer." ”
According to the study, 99% of cervical cancer cases are related to HPV infection, and the chance of HPV infection in women is as high as 85%-90% in their lifetime.
At present, cervical cancer implements tertiary prevention, primary prevention and secondary prevention is HPV vaccination and regular cervical screening, which can effectively block cervical precancerous lesions and cervical cancer.
HpV vaccination, also known as cervical cancer vaccine, can prevent up to 90% of cervical cancer caused by HPV infection. The bivalent vaccine is suitable for women aged 9 to 45 years, the quadrivalent vaccine is suitable for women aged 20 to 45 years, the nine-valent vaccine is suitable for women aged 16 to 26 years, and pregnant women cannot be vaccinated.
Secondary prevention requires women over 21 years of age or women who have had sex for more than 3 years, advocating cervical cytology or TCT screening every 2 years, if the above tests find high-risk HPV positive or cytological abnormalities, it is necessary to do colposcopy, if necessary, take tissue on the cervix, do pathological histological diagnosis to determine whether the cervix has precancerous lesions.
Upstream journalist Shi Heng